AU2001248765A1 - Oxadiazole derivatives having therapeutic or preventive efficacies against glomerular disorders - Google Patents
Oxadiazole derivatives having therapeutic or preventive efficacies against glomerular disordersInfo
- Publication number
- AU2001248765A1 AU2001248765A1 AU2001248765A AU4876501A AU2001248765A1 AU 2001248765 A1 AU2001248765 A1 AU 2001248765A1 AU 2001248765 A AU2001248765 A AU 2001248765A AU 4876501 A AU4876501 A AU 4876501A AU 2001248765 A1 AU2001248765 A1 AU 2001248765A1
- Authority
- AU
- Australia
- Prior art keywords
- preventive
- therapeutic
- oxadiazole derivatives
- efficacies against
- glomerular disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000-120235 | 2000-04-21 | ||
| JP2000120235 | 2000-04-21 | ||
| PCT/JP2001/003215 WO2001083464A1 (en) | 2000-04-21 | 2001-04-16 | Oxadiazole derivatives having therapeutic or preventive efficacies against glomerular disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001248765A1 true AU2001248765A1 (en) | 2001-11-12 |
Family
ID=18631081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001248765A Abandoned AU2001248765A1 (en) | 2000-04-21 | 2001-04-16 | Oxadiazole derivatives having therapeutic or preventive efficacies against glomerular disorders |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001248765A1 (en) |
| WO (1) | WO2001083464A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030105144A1 (en) | 2001-04-17 | 2003-06-05 | Ping Gao | Stabilized oral pharmaceutical composition |
| JP4632288B2 (en) * | 2002-02-27 | 2011-02-16 | 塩野義製薬株式会社 | Solid formulation with improved absorption of poorly water-soluble drugs |
| WO2003080041A1 (en) * | 2002-03-27 | 2003-10-02 | Shionogi & Co., Ltd. | Remedies for arthritis deformans |
| HUE059464T2 (en) * | 2003-04-11 | 2022-11-28 | Ptc Therapeutics Inc | 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| AU2004231106A1 (en) * | 2003-04-14 | 2004-10-28 | The Institutes For Pharmaceutical Discovery, Llc | N- (((((1,3-thiazol-2-yl) amino) carbonyl) phenyl) sulfonyl) phenylalanine derivatives and related compounds for the treatment of diabetes |
| EA200501710A1 (en) | 2003-04-30 | 2006-06-30 | ДЗЕ ИНСТИТЬЮТС ФОР ФАРМАСЬЮТИКАЛ ДИСКАВЕРИ, ЭлЭлСи | SUBSTITUTED CARBON ACIDS |
| EP1650199A4 (en) | 2003-07-30 | 2008-11-19 | Shionogi & Co | Sulfonamide derivative having isoxazole ring |
| GB0601744D0 (en) * | 2006-01-27 | 2006-03-08 | Novartis Ag | Organic compounds |
| US8148410B2 (en) * | 2007-12-10 | 2012-04-03 | Actelion Pharmaceuticals Ltd. | Thiophene derivatives as agonists of S1P1/EDG1 |
| US9873677B2 (en) | 2014-03-06 | 2018-01-23 | Ptc Therapeutics, Inc. | Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid |
| WO2017075312A1 (en) | 2015-10-30 | 2017-05-04 | Ptc Therapeutics, Inc. | Methods for treating epilepsy |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ID29293A (en) * | 1997-07-22 | 1999-01-28 | Shionogi & Co | COMPOSITION FOR TREATMENT OR PREVENT GLOMERULOPATHY (Fraction from No. W20000054) |
| WO2000015213A1 (en) * | 1998-09-11 | 2000-03-23 | Shionogi & Co., Ltd. | Remedal or preventive agent for congestive heart failure |
-
2001
- 2001-04-16 WO PCT/JP2001/003215 patent/WO2001083464A1/en active Application Filing
- 2001-04-16 AU AU2001248765A patent/AU2001248765A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001083464A1 (en) | 2001-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001261262A1 (en) | Glaucoma treatment device | |
| AU2002213002A1 (en) | Antisense inhibition of caspase 6 expression | |
| IL153425A0 (en) | Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders | |
| IL151890A0 (en) | Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
| AU2001246367A1 (en) | Screw connection | |
| HK1044582A1 (en) | Screw member | |
| AU2001248765A1 (en) | Oxadiazole derivatives having therapeutic or preventive efficacies against glomerular disorders | |
| EP1148637A3 (en) | Level adjustment circuit | |
| AU2001246916A1 (en) | Oxadiazole derivatives having anticancer effects | |
| AU2001256201A1 (en) | Device for administering implants | |
| AU2001256855A1 (en) | Preparation for the prevention and treatment of ocular disorders | |
| EP1180737A3 (en) | Adjustment device | |
| AU2001260834A1 (en) | The treatment of herpes | |
| AU4498201A (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment ofpain | |
| AU2000263864A1 (en) | Tissue specific prodrug | |
| IL151765A0 (en) | Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain | |
| AU2002236781A1 (en) | Treatment for snoring | |
| EP1308156A4 (en) | Drug-containing solid dispersion having improved solubility | |
| AUPQ634300A0 (en) | Synergistic formulations | |
| AU1653101A (en) | Use of thiazole derivatives for treatment/prevention of p38 kinase mediated disorders | |
| AU2001248824A1 (en) | Thermotherapy device | |
| AU2001231107A1 (en) | Improved lactational | |
| AU2002221566A1 (en) | Novel benzimidazole derivatives for the treatment of gaba-alpha mediated disorders | |
| AU2001278388A1 (en) | Screw | |
| AU2000272704A1 (en) | Use of compounds for the treatment of obesity |